THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS - TUMMY TRIAL

Merve Sivridas  ¹     L. J. J. Derijks  ¹     Paul Boekema  ¹     Adriaan A. Van Bodegraven  ²     Lennard Gilissen  ³     Tessa E.H. Römkens  ⁴     Dennis R. Wong  ⁵     Rob Creemers  ⁵     Floris C. Loeff  ⁶     Theo Rispens  ^6    
1 Máxima Medical Center, Veldhoven/Eindhoven, Netherlands
² Zuyderland Medical Center, Sittard-Geleen, Netherlands
³ Catharina Ziekenhuis, Eindhoven, Netherlands
⁴ Jeroen Bosch Hospital, Den Bosch, Netherlands
⁵ Zuyderland Medical Centre, Clinical Pharmacy & Toxicology, Sittard-Geleen
⁶ Sanquin Diagnostic Services, Amsterdam, Netherlands

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)